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ABSTRACT 
 
POPULATION ATTRIBUTABLE FRACTION OF SMOKING FOR   
TUBERCULOSIS (TB) DISEASE INCIDENCE AND TB MORTALITY IN HIGH-
BURDEN TB COUNTRIES 
by 
 
GENET AMERE 
 
_____________________ 
 
 
Background: Globally, there are 10 million new cases of tuberculosis (TB) 
disease annually and 95% of cases occur in low- and middle-income countries 
(LMIC). More than 1 billion people use tobacco, and 80% of tobacco users reside 
in LMIC. Smoking approximately doubles the risk of TB disease and is 
associated with excess mortality during TB treatment. We aimed to estimate the 
proportion of annual incident TB cases and TB mortality attributable to tobacco 
smoking in high burden TB countries. 
Methods: To estimate population attributable fractions (PAF), we obtained 
country specific estimates of TB incidence and TB mortality rates from the WHO 
2015 Global TB Report. Country specific smoking prevalence was estimated 
from WHO 2015 tobacco surveillance reports and the Tobacco Atlas. Risk ratios 
for the effect of smoking on TB incidence and TB mortality were obtained from 
previously published meta-analyses. Country specific PAF of smoking for TB 
disease were age and sex adjusted. 
 
 
 
 
Results: In high burden countries during 2014, an estimated 4.5 million adults 
developed TB disease and 163,000 people died from TB. An estimated 740 
million adult smokers lived in those high burden countries in 2014. We estimated 
that tobacco smoking was attributable for 17.7% (95% confidence interval [CI] 
8.6-21.9%) of TB cases and 15.0% (95% CI 1.9-31.6%) of TB mortality. Of the 
high burden countries, Russia had the highest proportion of smoking attributable 
TB disease (31.8%, 95% CI 16.0-37.8%) and death (28.1%, 95% CI 3.8-51.3%). 
India had the greatest absolute number of TB cases (233,000) and TB deaths 
(7,400) attributable to smoking. Men (30.5%, 95% CI 14.9%-36.9%) had a 
greater proportion of TB cases attributable to smoking than women (4.7%, 95% 
CI 1.9%-6.2%).  
Conclusion: In high-burden TB countries, nearly one-sixth of all TB cases and 
TB deaths were attributable to smoking. Our findings highlight the need for 
tobacco control in high TB burden regions and specifically among patients with 
TB.  Reaching key populations and integrating smoking cessation efforts into TB 
programs will be essential to achieve global TB control goals. 
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CHAPTER I 
INTRODUCTION 
1.1 Background 
Tuberculosis (TB) is a bacterial infection caused by Mycobacterium 
tuberculosis (MTB), which is transmitted via droplet nuclei. According to 
World Health Organization (WHO), 10.4 million people developed TB 
disease and 1.8 million died from it in 2015. The majority of TB disease 
(87%) occurs in 30 high burden countries and 95% of cases occur in low- 
and middle-income countries (LMIC) (WHO, 2015a, 2016a). 
A third of the world population is infected with MTB but are 
asymptomatic and non-infectious. A small proportion of those infected will 
develop TB disease; the lifetime risk of developing TB disease is 
estimated at 10%. However, the risk of developing TB disease increases 
in immunocompromised people such as patients with HIV/AIDS, 
malnutrition, diabetes, and among individuals who use tobacco (WHO, 
2015). 
Tobacco smoking is the most preventable cause of premature 
death and disease worldwide (CDC, March 15, 2016). The risk of diseases 
such as lung cancer, chronic obstructive pulmonary disease, and 
cardiovascular disease increase with smoking. Globally, more than 1 
billion people use tobacco, which kills more than 5 million people annually 
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and this figure is expected to exceed 8 million by 2030 on current trends, 
with more than 80% of deaths occurring in LMIC (WHO, 2016a). 
The prevalence of smoking is 4.4 times higher in men than in 
women globally. However, there is regional variation in tobacco 
consumption in both males and females. For instance, in Americas Region 
(1.6 times) and European Region (2 times) higher in men, whereas South-
East Asia Region (9.3 times) and Western Pacific Regions (11.4 times) 
higher among men than women. Furthermore, countries with large 
population have sex-linked disparity in tobacco consumption. For 
example, the male smoking prevalence rates are 22 times higher and 23 
times higher than women in China and India, respectively (WHO, 2010).  
To achieve the 2030/35 newly adopted Sustainable Development 
Goals (SDG) which includes ending TB epidemic (WHO, 2015e), it is 
important to address all risk factors including smoking.  Although smoking 
prevalence is decreasing in most developed countries, many countries 
with the highest TB burden have very high smoking rates. For instance, 
smoking prevalence among U.S. adults declined from 20.9% to 16.8% 
between 2005 and 2014 (Jamal et al., 2015). However, in Indonesia 
(67.0%), Russia (60.2%), and China (52.9%) the majority of the adult male 
population smokes (WHO, October 2015 ).  
Although the number of legislated tobacco control polices increased 
globally from 2007 to 2014, including in LMIC, implementation of tobacco 
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control policies is still at low levels in most LMIC (Anderson, Becher, & 
Winkler, 2016; Bump & Reich, 2013). In addition, many tobacco 
corporations have shifted the focus of advertisement and distribution from 
high-income countries to LMIC where the burden of TB is highest 
(Mendez, Alshanqeety, & Warner, 2013). The limited policy 
implementation and the shift in tobacco marketing strategies would impact 
the burden of TB in LMIC. 
Tobacco use greatly increases the risk of TB infection, TB disease, 
and TB death. Systematic reviews performed by Bates et al. and Slama et 
al. in 2007 indicated that smokers are almost twice more likely to be 
infected with TB than non-smokers (Bates et al., 2007; Slama et al., 
2007). Smokers are also estimated to have twice the risk of developing TB 
disease and die from TB (Bates et al., 2007; Lin, Ezzati, & Murray, 2007; 
Slama et al., 2007). In addition, tobacco smoking increases the risk of 
recurrent TB after treatment completion (Mahishale, Patil, Lolly, Eti, & 
Khan, 2015; Yen et al., 2014). Yen YF et al reported that after successful 
treatment completion, the risk of TB recurrence among subjects who 
smoked >10 cigarettes a day was two times more than among subjects 
who never/former smokers. Overall, more than 20% of adult TB cases and 
16% of all TB cases in the world are attributable to smoking (Lonnroth et 
al., 2010). The objective of this study is to determine the proportion of TB 
disease and TB mortality attributable to smoking in the 32 high burden TB 
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countries by estimating age and sex specific population attributable 
fraction using WHO data. 
1.2 Gap and Purpose of Study 
Multiple epidemiologic studies have reported that smoking 
increases the risk of TB infection, TB disease, and TB death. However, 
previous studies have not estimated the proportion of TB disease 
incidence due to smoking adjusted for age and sex. Previous studies have 
also not estimated the proportion of TB deaths attributable to smoking in 
high burden countries. This study addresses whether the changes in the 
global TB epidemic and changes in global smoking prevalence have 
impacted the relative impact of smoking on the public health burden of TB.    
The specific objectives of this study are: 
1. To estimate the proportion of TB disease incidence due to 
tobacco smoking among 32 high burden TB countries. 
2. To estimate the proportion of TB deaths due to tobacco 
smoking among 32 high burden TB countries. 
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CHAPTER II 
REVIEW OF LITERATURE 
2.1 Epidemiology of TB and Smoking 
Although incident TB is decreasing worldwide, the number of TB 
cases are still increasing due to better detection and reporting, and 
population growth. For instance, estimated TB incidence in the Pacific has 
remained high but stable from 2000 to 2013. Using data from the WHO 
annual TB surveillance for 22 Pacific island countries and territories, TB 
case notification rate increased by 58%, from 146 to 231 per 100,000 
population in the same period (Viney et al., 2015). In another study 
notified TB cases increased from 24 878 in 2006 to 26 517 in 2014 
(Noeske, Nana Yakam, & Abena Foe, 2016).  
Globally, smoking prevalence will get worse without additional 
policies and strategies. MPOWER is a comprehensive set of tobacco 
control policies which consists of six basic strategies: monitor tobacco 
use, protect people from tobacco smoke, offer help to quit tobacco use, 
warn about the dangers of tobacco, enforce bans on tobacco advertising, 
promotion and sponsorship, and raise taxes on tobacco (WHO, 2008). 
Méndez et al. estimated that global smoking prevalence would be 22.7% 
by 2020 and 22.0% by 2030, however if MPOWER implemented 100% 
globally, the prevalence would reduce  to 15.4% in 2020 and 13.2% in 
2030 (Mendez, Alshanqeety, & Warner, 2013). Another study conducted 
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by Bilane et al.  also estimated that there will be 1·1 billion tobacco 
smokers (95% credible interval 700 million to 1·6 billion) in 2025 globally. 
The authors predicted that smoking prevalence will be higher among 
African men and eastern Mediterranean men and women if the current 
trends continue. Tobacco epidemic is at risk of worsening in LMIC without 
effective and sustainable tobacco control measures (Bilano et al., 2015). 
2.2  The Association between TB Disease and Smoking  
Smoking prevalence was higher among TB patients (39.3 %) than 
the general population (23.95 %) (Jimenez-Fuentes et al., 2016). A study 
in Iran found that the prevalence of cigarette smoking was 22% among 
newly diagnosed TB patient vs 13.9% among the general population of 
Iran (Aryanpur et al., 2016). A cross-sectional study conducted in South 
Africa also reported that patients with active TB had very high rates of 
smoking (56%) prevalence (Brunet et al., 2011). 
Large cross-sectional studies in south and central India conducted 
in 2007 and 2014, respectively, reported a positive association between 
smoking and TB disease. The study in south India found that smokers had 
a 2.1 (95% confidence interval (CI), 1.7–2.7) times higher risk of TB 
disease than non-smokers did which is similar with the case control study 
in south India (Kolappan & Gopi, 2002; Kolappan, Gopi, Subramani, & 
Narayanan, 2007). In addition, the study in central India reported a strong 
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dose response relationship between TB disease and tobacco smoking. 
Compared to non-smokers, the adjusted prevalence odds ratio (aOR) for 
mild, moderate and heavy tobacco smokers were 2.28 (95% C1 0.43–
3.63), 2.51 (1.59–3.96) and 2.74 (1.60–4.69) respectively (Rao et al., 
2014). A recent multicenter cross-sectional study in Spain based on 5,846 
TB cases found that smoking was associated with pulmonary TB with an 
aOR of 1.61(95%CI: 1.16 - 2.24) (Jimenez-Fuentes et al., 2016). 
Multiple case-control studies estimated the relationship between 
tobacco smoking and TB disease. A case-control study conducted in Hong 
Kong showed that TB patient were approximately 2 times more likely to 
have smoked than population control in both sex and all age group (Leung 
et al., 2003). In this study, the odds of ever smoking among TB patients 
were 2.44 (males) and 2.08 (females) aged 16-64 and 2.09 (males) and 
2.83 (females) aged >or = 65 compared to population control. 
A hospital based case-control study performed in Thailand reported 
that duration and amount of cigarette smoking had positive relationship 
with pulmonary TB (Ariyothai et al., 2004). Ariyothai et al. reported that 
compared to non- smoker, persons who had smoked >10 years had a 
higher risk of pulmonary TB (odds ratio (OR) = 2.96, 95% CI = 1.06-8.22). 
Those who smoked >10 cigarettes/day (OR = 3.98, 95% CI = 1.26-12.60) 
or >3 days/week (OR = 2.68, 95% CI = 1.01-7.09) had higher risk of 
pulmonary TB compared to non-smokers (Ariyothai et al., 2004). 
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Case-control studies conducted in India at different set up reported 
the association between tobacco smoking and TB disease. The study 
conducted at University Hospital showed a higher association than at 
district hospital.  Compared to nonsmoker, the adjusted odds of 
developing pulmonary TB among smokers were approximately 4 times 
(aOR,3.8, 95%CI, 2.0 to 7.0; P value, <.0001) vs 2 times (aOR,1.70, 
95%CI: 1.01-2.88) in University and rural hospitals, respectively 
(Dhamgaye, 2008; Prasad, Garg, Singhal, Dawar, & Agarwal, 2009). 
Prasad et al and Dhamgaye also showed amount and duration of smoking 
were also positively associated with pulmonary TB. The difference could 
be due to regional variation in smoking prevalence in India. In a large 
case-control study conducted in India, the prevalence risk ratio of TB 
disease was 2.9 (95% CI, 2.6-3.3) for ever-smokers compared with never-
smokers in adult men between 35 and 69 years of age (Gajalakshmi, 
Peto, Kanaka, & Jha, 2003). Another case-control study in south India 
also found that smoking was independently associated with pulmonary TB 
with a strong dose response relationship (age aOR 2.24. (95% CI 1.27 to 
3.94) (Kolappan & Gopi, 2002). 
Although smoking is less common in African countries, some 
studies reported the association between smoking and TB. A multicenter 
case–control study conducted in three West African countries (Guinea, 
Guinea Bissau, and The Gambia) reported that smoking was an 
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independent risk factor of pulmonary TB. The adjusted OR for both current 
and passive smoking were aOR 2.54 (95% CI 1.77-3.66) and 1.82 (95% 
CI 1.05-3.15) respectively (Lienhardt et al., 2005).  A case-control study in 
St Peter’s Tuberculosis Hospital in Ethiopia reported that the odds of 
pulmonary TB were higher among men smokers (43%) than controls 
(25%) with an aOR of 2.3 (95% CI 1.1–4.8) (Ramin, Kam, Feleke, Jacob, 
& Jha, 2008). 
Recent case-control study conducted in Istanbul (Turkey) reported 
that the odds of developing active TB were five times more among current 
smokers (OR 4.97, 95% CI: 3.2-7.5, p< 0.0001) than non-smokers 
(Ozturk, Kilicaslan, & Issever, 2014). The association was higher than that 
of from other countries (Ozturk et al., 2014). In a case-cohort study in 
northern California, where TB is not common, the odds of active TB in 
ever and past smoker were 1.34 (95% CI, 1.07- 1.66) and 1.37 (95%CI, 
1.07-1.75) respectively compared to never smoker. However, among 
current smokers, 46.3% TB cases vs 48.9% controls were current smoker 
with OR of 1.26 (95% CI 0.91 to 1.7) (Smith et al., 2015). The authors 
concluded that ever- and former smokers were at an increased risk of 
pulmonary TB disease when compared with never-smokers. 
Two cohort studies conducted in Hong Kong and Taiwan reported 
the association between smoking and TB disease. A retrospective cohort 
in Hong Kong for adults aged 65 years or older showed that the risk of 
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pulmonary TB among current smokers were 2.87 (95% CI, 2.00–4.11) 
times than among never smokers (Leung et al., 2004). A prospective 
study in Taiwan reported that the risk of active TB in current smokers was 
two (1.94 95%CI (1.01-3.73) times compared with never smokers (Lin, 
Ezzati, Chang, & Murray, 2009). Both studies showed a statistically 
significant dose–response relationship and adjusted for potential 
confounders like socio economic status (SES), age, sex, alcohol use, 
marital status, and chronic disease like diabetes mellitus. Lin et al. also 
found that the smoking-attributable fraction of TB disease was 17%. 
2.3 The Association between TB Mortality and Smoking   
Studies to date showed that smoking increases poor outcome 
among TB patients especially death. A large retrospective case-control 
study in south India, compared to never-smokers, among ever-smoker 
men 25-69 years of age, the prevalence risk ratio of death from TB were 
4.5 (95% CI, 4.0-5.0) and 4.2 (95% CI, 3.7-4.8) in urban and rural 
residents, respectively. The authors concluded that 61% of TB deaths are 
attributable to smoking, which is greater than deaths from cardio vascular 
disease or cancer in India (Gajalakshmi et al., 2003). A case-control study 
using a national representative data among men and women 30-69 years 
of age conducted in India reported that, compared to non-smokers, 
mortality from TB were significantly higher in smokers with a risk ratio of 
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3.0 (99% CI, 2.4 to 3.9) and 2.3 (99% CI, 2.1 to 2.6) in women and men, 
respectively (Jha et al., 2008). 
A case-control study in Hong Kong examined all causes and 
specific cause mortality associated with smoking. Lam et al. reported that 
among men, mortality from TB in smokers was 2.54 (95% CI 1.24-5.22) 
times than in non-smokers. The association was not significant in women 
(adjusted risk ratios of 1.49, 95% CI: 0.18-12.57) (Lam, Ho, Hedley, Mak, 
& Peto, 2001). A large population study in China based on 15,497 TB 
deaths, reported that the risk ratio for TB death in smokers vs non-
smokers were 1.5 (95%CI 1.4–1.6) and 1.6 (95%CI 1.5–1.7) in men and 
women, respectively. Jiang et al. also reported that smoking-attributable 
fraction of TB death were 22.5% in men and 6.6% in women (Jiang et al., 
2009). 
Sitas et al. conducted a case-control study in South Africa using 
South African death notification system. Based on 416 TB deaths, 20% of 
TB deaths were attributable to smoking with OR of 1.61 (95% CI, 1.23 to 
2.11). TB deaths attributable to smoking was 28% among men and 7% 
among women (Sitas et al., 2004). A case-control study in rural 
Bangladesh based on 78 pulmonary TB deaths reported that 35.1% of TB 
mortality attributable to smoking among men 25-69 years old. The 
associated odds were 1.82 (99% CI, 0.7- 4.7) among ever-smoker vs 
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never-smoker, after adjusting for differences in age, education and use of 
chewing tobacco (Alam et al., 2013). 
A large cohort study in India followed men 35 years and older for 13 
years and estimated TB deaths among smokers. After adjusting for 
potential confounders (age, education, and smokeless tobacco use), the 
risk of death from TB among smokers were 2 times more than among 
non-smoker (RR 2.12, 95% CI: 1.70, 2.66). The authors reported that the 
risk was higher for bidi smokers (RR 2.63, 95% CI: 2.05, 3.38) than 
cigarette smokers (RR 1.68, 95% CI: 1.28, 2.20). Pednekar et al. 
concluded that 32% of TB mortality was attributable to bidi smoking 
(Pednekar & Gupta, 2007). However, a cohort study in Taiwan reported 
that smoking was not significantly associated with TB death (Hazard ratio 
[HR] 1.420,95% CI 0.872–2.313) when adjusted for independent 
prognostic factors such as age, the presence of underlying disease, 
symptom duration 60 days, extra-pulmonary involvement, serum albumin 
level >3.5 g/dl, and delayed anti-TB treatment (Wang et al., 2007). 
Although the study in Taiwan included all age, both sex, and shorter 
duration than the study in India. 
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2.4 Summary of literature review 
 Highlights from the literature review of previous studies include: 
 TB incidence and smoking prevalence is changing 
globally  
 Studies to date suggested that smoking is associated 
with risk of developing TB with a strong dose response 
relationship. 
 Most Studies suggested the association between 
smoking and TB mortality with some controversy as 
reported by a cohort study in Taiwan.  
 The association between smoking and TB were higher in 
men. 
 14 
 
CHAPTER III 
MANUSCRIPT 
Introduction 
Tuberculosis (TB) remains one of the leading causes of morbidity 
and mortality worldwide. In 2015, 10.4 million people developed active TB 
and 1.8 million died from the disease (WHO, 2016a). The majority of TB 
disease (87%) occurs in 30 high burden countries and an estimated 95% 
of TB cases and deaths occur in low- and middle-income countries (LMIC) 
(WHO, 2016a, 2016c). Currently, there are more than 1 billion tobacco 
users in the world and nearly 80% of them live in LMIC, where the burden 
of tobacco and TB related illness and death is highest (WHO, 2015c, 
2016b). Tobacco is the second major cause of death in the world and kills 
half of all lifetime users. Annually, tobacco kills 6 million people and more 
than 5 million deaths are due to direct tobacco use  (WHO, 2016b). The 
co-occurrence of both smoking and TB in LMIC is a major public health 
problem.   
Although tobacco use is declining in many high-income countries, it  
is increasing in LMIC (Mendez et al., 2013) where tobacco control policies 
are not well established. In 2015, the World Health Organization (WHO) 
projected that smoking prevalence will decrease in all WHO regions 
except Africa and Eastern Mediterranean regions where smoking is 
expected to increase (WHO, 2015b). Although TB disease incidence is 
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declining globally, TB incidence rates are still high in African and Asian 
regions (Viney et al., 2015; WHO, 2013a, 2015d).  However, the extent to 
which changes in smoking prevalence may impact changes in global TB 
incidence trends is largely unknown.  
The risk of active TB is associated with immunosuppression and 
also with modifiable behaviors such as tobacco use (Maurya, Vijayan, & 
Shah, 2002; WHO, 2016c). Tobacco smoking approximately doubles the 
risk of TB infection, TB disease, and TB death (Bates et al., 2007; Lin, 
Ezzati, & Murray, 2007; Slama et al., 2007). Cohort studies have 
estimated that people who smoked tobacco are more than twice as likely 
to develop active TB disease compared to non-smokers (Alcaide et al., 
1996; Bates et al., 2007; Leung et al., 2004). Moreover, smokers are more 
likely to die from TB disease than non-smokers (Gajalakshmi et al., 2003; 
Lin et al., 2007; Slama et al., 2007). Studies also reported that tobacco 
smoking increases the risk of recurrent TB after treatment completion 
(Mahishale, Patil, Lolly, Eti, & Khan, 2015; Yen et al., 2014). Previous 
reports estimated that more than 20% of adult TB cases are attributable to 
smoking, which is more than HIV (16%) and diabetes (15%) (Lonnroth et 
al., 2010; Lonnroth, Roglic, & Harries, 2014). However, previous estimates 
of the proportion of TB cases attributable to smoking were not adjusted for 
age and sex nor did they include sensitivity analyses to assess the 
potential bias due to smoking prevalence measurement error. In addition, 
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previous studies have not estimated the proportion of country specific TB 
deaths attributable to smoking in high burden countries.  
The goal of this study was to estimate the proportion of TB disease 
incidence due to tobacco smoking in 32 countries with a high burden of 
TB. Second, among the same countries, we aimed to estimate the 
proportion of TB deaths due to tobacco use. We estimated the proportions 
of TB disease and death using standard population attributable fraction 
calculations.   
METHODS 
Epidemiological Data Sources and Study Design   
We used six population-based cross-sectional data sources to 
conduct this population attributable fraction study. We obtained TB case 
notification and TB mortality data from 2015 Global TB Report (WHO, 
2015a). Tobacco use data came from the Global Adult Tobacco Survey 
(WHO, 2014), the WHO Global Report (WHO, 2015b), Tobacco Free 
Initiative country profiles (WHO), and the Tobacco Atlas (Atlas). We 
obtained population data from the United States Census Bureau (Census, 
2015).   
The Global TB Report has been published by WHO annually since 
1997 to provide epidemiologic surveillance of the global TB epidemic and 
includes TB data at regional and country levels (WHO, 2016c). Global 
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Adult Tobacco Survey is a household survey developed in 2007 as part of 
the Global Tobacco Surveillance System which collects nationally 
representative data and includes tobacco use data on persons aged 15 
years old and older. To date Global Adult Tobacco Survey includes 25 
LMIC where tobacco burden is high (WHO, 2014). The 2015 WHO Global 
Smoking prevalence report includes estimated age specific current 
tobacco smoking prevalence based on Bayesian hierarchical meta-
regression modelling and projected tobacco smoking prevalence trends in 
WHO regions (WHO, 2015b). Tobacco Free Initiative established by WHO 
in 1998  and provide country specific tobacco surveillance data (WHO).  
Study Population Selection Criteria 
Our study participants included adult male and female individuals 
aged 15 years and older who lived in the 32 high TB-burden countries. 
The 30 high TB-burden countries were defined by the 2016 WHO Global 
TB Report as the top 20 countries with the highest absolute number of TB 
cases and the top 10 countries with the highest estimated incidence rates 
of TB cases with at least 10,000 new cases per year (WHO, 2014). We 
added Uganda and Afghanistan which were not among the 30 2016 WHO 
countries but they were included in 2015 global TB report among the 22 
high burden-TB countries (WHO, 2015a, 2016c). 
Tuberculosis Incidence and Mortality  
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To estimate country-specific TB incidence rates, we obtained TB 
notification data from 2015 global TB report for the 32 highest TB-burden 
countries (WHO, 2015d). Although TB incidence is not directly measured 
at the country level, TB case notification rates are directly measured to 
provide proxy estimates for TB incidence rates which include notified and 
undiagnosed TB cases (WHO, 2015d). A TB notification indicates that TB 
is diagnosed in a patient and is reported within the national surveillance 
system to WHO (WHO, 2013b). The TB notification rate is defined as the 
number of new and relapse TB cases notified in a given year per 100,000 
population (WHO, 2013b). In 2014, 205 countries reported TB incidence 
data to WHO (WHO, 2015d). We used TB notification rates for our 
estimates of TB incidence as it includes sex and age specific data. For 
countries without sex specific data (for example, Mozambique and Papua 
New Guinea), we used the global male to female TB case notification ratio 
(1.7) (WHO, 2015d). In 2014, notifications of newly diagnosed TB cases 
represented 63% (60%-66%) of estimated incident cases in the world 
(WHO, 2015d).  
To determine country-specific rates of TB mortality, we used the 
reported percentage of patients with TB whose treatment outcome was 
indicated as TB deaths. A TB death was defined as a TB patient who died 
from any cause during treatment (WHO, 2015d). We extracted 2013 TB 
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mortality data from the 2015 global TB report, except for Congo (we used 
2011 data) (WHO, 2013a).  
Relative Risk for TB disease and TB Mortality Associated with Smoking 
We obtained relative risk estimates for the association between 
smoking and TB incidence, and the association between smoking and TB 
mortality from previously published studies reported by Bates et al., Slama 
et al., and Lin et al. in 2007 (Bates et al., 2007; Lin et al., 2007; Slama et 
al., 2007; van Zyl Smit et al., 2010). The risk of TB disease in smokers 
versus non-smokers was 2.3 (95% CI 2-2.8) (Bates et al., 2007), 2.3 (95% 
CI 1.8-3.0) (Slama et al., 2007), and 2.0 (95% CI 1.6-2.6 ) (Lin et al., 
2007). The reported risk ratios for TB mortality, comparing smokers to 
non-smokers, were 2.1 (95% CI 1.4-3.4) (Bates et al., 2007), 2.2 (95% CI 
1.3-3.7 ) (Slama et al., 2007), and 2.0 (95% CI 1.1-3.5 ) (Lin et al., 2007). 
We used a relative risk of 2.3 (95% CI 1.5-2.8) for smoking associated 
with TB disease as reported in two systematic reviews. For TB mortality, 
we used a relative risk of 2.0 (95% CI 1.1-3.7) comparing smokers to non-
smokers.  
Smoking Prevalence 
Smoking prevalence data were obtained from four previously 
mentioned data sources for the 32 countries (Table 1).  Age and sex 
specific smoking prevalence data were extracted from the Global Adult 
Tobacco Survey for 12 countries (WHO) which was our primary data 
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source and from 2015 WHO global report on trends in prevalence of 
tobacco smoking for 14 countries (WHO, 2015b). When country data were 
not available in the primary data source, we checked the next available 
data sources as seen in Figure 1. For countries without age stratification 
data, we used Tobacco Free Initiative country profiles and the Tobacco 
Atlas to estimate smoking prevalence (Atlas; WHO) . 
The smoking prevalence data used for this study was based on the 
definition of current tobacco use except for Afghanistan, Angola, and 
Central African Republic. We used current tobacco (smoked and 
smokeless) prevalence for Kenya and Pakistan since age distribution data 
were available for both types of tobacco use. For Afghanistan, Angola, 
and Central African Republic, we used daily tobacco use. Current tobacco 
use included daily smoking and occasional smoking of any type of smoked 
and smokeless tobacco product (Bilano et al., 2015; Prignot, Sasco, 
Poulet, Gupta, & Aditama, 2008). Smoked tobacco included manufactured 
cigarettes, bidi, hukkah (waterpipes), hand–rolled cigarettes, pipes full of 
tobacco, cigars, cherrots or, cigarillos, and any other. Others included 
dhaba (waterpipes made of bamboo) (Bilano et al., 2015).  
Population Data 
The 2014 age and sex specific population distributions data for 32 
highest TB burden countries were extracted from the International Data 
Base of the United States’ Census Bureau (Census, 2015). 
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Statistical Calculations  
We calculated crude estimates of population attributable fractions 
(PAF) for TB disease incidence and TB mortality for the 32 countries 
(Figure 2) (Stevenson et al., 2007). Age and sex specific estimates and 
age-adjusted estimates for TB disease incidence were calculated for the 
26 countries where age specific smoking prevalence were available. To 
calculate TB incidence PAF, we used estimated smoking prevalence, TB 
incidence (TB notification rate), and relative risk of TB disease comparing 
smokers to non-smokers. For TB mortality PAF calculation, we used 
estimated smoking prevalence, TB mortality rate (reported TB death rate), 
and relative risk of TB mortality associated with smoking.  
We used the 95% confidence intervals (CI) of the relative risks from 
published estimates and 95% CI around smoking prevalence from WHO 
report to calculate the upper and lower PAF estimates for each country. 
We estimated the excess number of active TB cases attributable to 
smoking for each country in each age and sex group by multiplying age-
sex specific PAFs by the corresponding country-specific reported TB 
cases from WHO. The number of TB deaths attributable to smoking were 
estimated by multiplying the PAF for each country by the number of TB 
deaths in the corresponding country.  
Sensitivity Analysis  
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We estimated the amount of systematic error due to 
misclassification of smoking prevalence using the 95% CI around point 
estimates of smoking prevalence for each country. We recalculated PAF 
for each country using the smoking prevalence confidence interval range 
and compared the result with PAF calculation (the association between TB 
disease and TB death in smokers vs. non-smoker).  
RESULTS  
In 2014, there were an estimated 3.4 billion people over the age of 
15 years in the 32 high burden TB countries. In these high TB burden 
countries during 2014, over 4.5 million developed TB disease and 163,000 
died from TB. The estimated crude prevalence of smoking in the 32 
countries was 21.8% (N=731 million) with a higher prevalence among men 
(39.2%) compared to women (4.1%). 
The crude proportion of TB disease incidence attributable to 
tobacco smoking was 19.9% (894,891 excess cases) and the age-
adjusted proportion was 17.7% (759,846 excess cases) (Table 2). The 
country-specific proportion of TB disease attributable to tobacco smoking 
ranged from 5.0% (95%CI, 2.1-6.5%) in Ethiopia to 31.7% (95%CI, 16.0-
37.8%) in Russia (Table 2). Smoking-attributable TB disease was higher 
among men (30.5%) than among women (4.7%) (Table 3).  Among men, 
the proportion of TB disease attributable to smoking ranged from 8.7% in 
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Nigeria to 46.6% in Indonesia. Among women, the proportion ranged from 
0.5% in Nigeria to 22.0% in Russia (Table 3).  
Overall, 15.0% (95% CI 1.9%-31.6%) of TB deaths (an estimated 
24,773 reported deaths) in adults aged 15 years and older were 
attributable to tobacco smoking. The proportion of TB deaths attributed to 
smoking ranged from 3.8% (95%CI, 0.4%-9.5%) in Nigeria to 28.1% (95% 
CI, 3.8% to 51.4%) in Russia.  Russia (28.1%), Indonesia (25.8%), and 
Sierra Leone (24.2%) were the top 3 countries with the highest proportion 
of TB deaths attributable to tobacco smoking (Table 4).   Although the 
proportion of TB cases [14.2% (95% CI, 6.4% -17.7%)] and TB deaths 
[12.3 % (95% CI, 1.4%-27.4%)] attributable to tobacco smoking in India 
were low (ranked 19 and 22, respectively), the absolute number of TB 
cases and TB deaths are highest because of its population size.  
In sensitivity analysis accounting for smoking prevalence 
misclassification, we found that with the lowest estimates of smoking 
prevalence, the proportion of TB disease incidence attributable to smoking 
was 16.3% and the lowest proportion of TB deaths attributable to smoking 
was 12.1%. The highest estimated proportion of TB disease incidence and 
TB deaths attributable to smoking were 23.4% and 18.0%, respectively. 
(Table 5).  
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DISCUSSION  
Overall, we found that tobacco smoking accounted for an estimated 
17.7% of TB disease incidence and 15.0% for TB mortality in 32 high 
burden TB countries. The proportion of TB disease attributable to smoking 
was more than six times higher in men compared with women. The larger 
proportion of TB disease due to smoking in men compared with women 
demonstrates the disparity of smoking prevalence among men and 
women. Our results suggest that strong tobacco control policies and 
programs in LMIC, and specifically within TB control programs, would help 
reduce the global burden of TB. 
Previous studies from individual countries have estimated the 
proportion of TB incidence attributable to smoking and reported findings 
consistent with our results. For example, a 2009 study from Taiwan 
reported that 17% of TB cases were attributable to smoking (Lin et al., 
2009).  Another study conducted in India reported that 14% of TB cases 
were attributable to smoking (Kolappan et al., 2007). Our findings 
suggested that smoking accounted for more TB disease among men than 
among women across countries, a result consistent with a study from 
Hong Kong that reported 33% of TB cases attributable to smoking among 
men and 9% in women (Leung et al., 2004).  
In most countries, smoking prevalence among TB patients is higher 
than the general population. For example, 43% of men with TB disease in 
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Ethiopia were ever smoker and 56% of TB patients in South Africa were 
current smokers (Brunet et al., 2011; Ramin et al., 2008). According to our 
study, tobacco smoking was responsible for nearly 18% of TB disease in 
32 high TB burden countries. Our estimate is lower than a 2010 study by 
Lonnroth et al, which estimated that 21% of TB disease incidence was 
attributable to smoking among 22 high TB burden countries (Lonnroth et 
al., 2010). Our study included 10 additional countries than the previous 
study and we adjusted for age, which may partially explain our lower 
estimate of the proportion of TB due to smoke. Moreover, the Lonnroth et 
al study used smoking prevalence data from 2008 and the global 
prevalence of smoking decreased between 2008 and 2014 when our 
smoking prevalence estimates were measured. For example, from 2008 to 
2014 smoking prevalence in Russia and China reduced by 10% (49.0% to 
39.1%) and 6% (34.5% to 28.1%), respectively (Lonnroth et al., 2010).   
Although only an ecologic-level hypothesis, it is plausible that the 
global reduction in smoking prevalence during the past decade also 
reduced TB incidence rates.  For example, the reduction in smoking 
prevalence in Russia and China correlated with reductions in TB incidence 
during the past 10 years.  The TB incidence rate per 100,000 population 
per year reduced from 107 to 84 in Russia and from 97 to 68 in China 
between 2008 and 2014 (WHO, 2011, 2014, 2015d).    
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Previous studies from individual countries have reported smoking-
attributable TB mortality. For example, 25%, 32%, and 35% of TB deaths 
in men were attributable to smoking in South Korea, India, and 
Bangladesh, respectively (Alam et al., 2013; Jee et al., 2009; Pednekar & 
Gupta, 2007). In South Africa, TB mortality attributable to smoking was 
20% in both sexes (Sitas et al., 2004), which is modestly higher than our 
estimate of 16%, likely due higher smoking prevalence estimates used by 
Sitas et al. A study in China (Jiang et al., 2009) also showed high rate of 
TB mortality attributable to smoking which is in agreement with our study. 
Jiang et al estimated that TB deaths in 22.5% of men and in 6.6% of 
women were attributable to smoking.  
Our findings indicated that smoking has an important effect on TB 
disease incidence and TB mortality. The estimated proportion of TB 
disease attributable to diabetes and HIV is likely less than the proportion 
due to smoking. Incorporating all risk factors including smoking in TB 
prevention program is therefore essential. The considerable impact of 
smoking on TB epidemics highlight the importance of promoting smoking 
cessation in people at risk of TB, especially in LMIC where the prevalence 
of smoking and the burden of TB are highest.  
Our study had a number of limitations. First, this study relied on 
reported TB cases that underestimated the excess number of TB cases 
and deaths caused by tobacco smoking. Although an estimated 63% of 
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TB cases were reported to WHO in 2014, only an estimated 50% of TB 
cases were reported among the 32 high burden countries (WHO, 2015d). 
However, low report rates did not affect the estimates of population 
attributable fraction. Second, TB cases and deaths due to secondhand 
smoke were not included in our analyses which may underestimate our 
estimates of the proportion of smoking-attributable TB disease and death 
Third, smoking prevalence measurement and data collection methods 
varied across countries and it did not provide dose rate and duration of 
exposure to smoke. Although most countries used WHO guidelines to 
collect smoking prevalence data, study participants could underreport their 
tobacco use especially for products other than cigarettes in developing 
countries. The estimates used for this study were based on the most 
current and reliable nationally representative data source, a strength to 
our study. Further, we applied sensitivity analysis for smoking prevalence 
and adjusted for age to improve estimates. 
Conclusion 
Smoking plays a substantial role in the global TB pandemic, 
including increasing the risk of TB disease and TB death in high TB 
burden countries. Smoking cessation efforts need to be incorporated in TB 
programs to reduce TB mortality. In addition, strong and coordinated 
global tobacco control efforts are needed from every country and 
28 
 
 
 
especially in high burden countries to avert TB disease and death due to 
smoking. 
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Lists of Tables  
Table.3.1: Country specific current tobacco smoking prevalence data   
Global Adult Tobacco 
Survey (WHO)  
Global Tobacco 
Prevalence Report 
(WHO)  
Tobacco Free 
Initiative  
(WHO)  
The Tobacco 
Atlas 
 
Bangladesh Cambodia DR of Korea Afghanistan a  
Brazil Congo Papua New Guinea Angola a 
China Ethiopia  CAR a 
India Lesotho  DR Congo 
Indonesia  Liberia   
Kenya b Mozambique   
Nigeria Myanmar   
Pakistan b Namibia   
Philippines  Serra Leon   
Russia  South Africa   
Thailand Tanzania   
Vietnam  Uganda    
 Zambia    
 Zimbabwe    
  
a. Daily tobacco use 
b. Smoke and smokeless tobacco use  
DR, Democratic Republic, CAR; Central African Republic 
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Table 2: Estimated proportion of TB disease attributable to tobacco smoking 
among adults in 32 high burden TB countries 
 
     
a. Current tobacco smoking prevalence1(WHO, 2015b, 2016c) 
b. TB disease incidence attributable to smoking calculated based on RR 2.3 (95%CI, 1.5-2.75) (crude) (Bates et 
al., 2007; van Zyl Smit et al., 2010) 
c. TB disease incidence attributable to smoking calculated based on RR 2.3 (95%CI, 1.5-2.75) (age adjusted)  
d. Number of excess cases based on age adjusted PAF except some countries with no age specific data 
e. Daily smoking prevalence (Atlas) 
 PAF (Population Attributable Fraction), CAR (Central African Republic), DRC (Democratic Republic of Congo), 
CI (Confidence interval), PNG (Papua New Guinea) 
Country Smoking 
prevalence a 
Crude PAF% TB disease 
b 
(95% CI) 
Age adjusted PAF% c 
(95% CI) 
Excess 
number of 
TB cases d 
Afghanistan 13.0e 14.4 (6.1-18.5) - -  
Angola 9.2e 10.7 (4.4-13.9) - -  
Bangladesh 23.0 23.0 (10.3-28.7) 18.3 (9.1-21.9) 32987 
Brazil 17.2 18.3 (7.9-23.1) 18.2 (8.0-28.0) 13052 
Cambodia 21.2 21.6 (9.6-27.1) 17.9 (8.6-21.8) 5555 
CAR 8.6e 10.0 (4.1-13.0)    
China 28.1 26.8 (12.3-33.0) 22.2 (11.3-26.4) 181158 
Congo 13.9 15.3 (6.5-19.6) 13.8 (6.3-17.2) 522 
DRC 6.4 7.7 (3.1-10.1)    
Ethiopia 4.3 5.3 (2.1-7.0) 5.0 (2.1-6,6) 5205 
India 14.0 15.4 (6.5-19.7) 14.2 (6.4-17.7) 215352 
Indonesia 34.8 31.2 (14.8-37.9) 24.8 (13.2-29.1) 74391 
Kenya 11.6 13.1 (5.7-175) 12.1 (5.4-15.2) 9810 
Lesotho 22.6 22.7 (10.2-28.3) 18.8 (9.4-22.4) 1567 
Liberia 12.1 13.6 (5.7-17.5) 13.3 (5.9-16.8) 221 
Mozambique 18.9 19.7 (8.6-24.9) 18.0 (8.2-22.3) 5140 
Myanmar 20.0 20.6 (9.1-26.0) 21.1 (9.9-26.0) 21556 
Namibia 21.6 21.9 (9.8-27.4) 20.2 (9.2-25.0) 1607 
Nigeria 3.9 4.8 (1.9-6.4) 9.9 (4-13.1) 8521 
North Korea 20.1 20.7 (9.1-26.0)    
Pakistan 19.1 19.9 (8.7-25.1) 17.3 (8.1-21.3) 48697 
PNG  26.3 25.5 (11.6-31.5)    
Philippines 28.3 26.9 (12.4-33.1) 24.0 (11.7-29.1) 11295 
Russia 39.1 33.7 (16.4-40.6) 31.8 (16.0-37.8) 31260 
Sera Leone 31.9 29.3 (13.8-35.8) 27.0 (13.0-32.7) 1974 
South Africa 19.4 20.1 (8.84-25.4) 19.1 (8.7-23.7) 52377 
Tanzania 16.3 17.5 (7.5-22.2) 11.6 (5.2-14.5) 6378 
Thailand 24.0 23.8 (10.7-29.6) 24.0 (18.6-51.9) 8210 
Uganda 10.1 11.6 (4.8-15.0) 10.8 (4.6-13.7) 4400 
Vietnam 23.8 23.6 (10.6-29.4) 19.5 (9.8-23.3) 9724 
Zambia 14.6 16.0 (6.8-20.4) 14.7 (6.6-18.4) 4926 
Zimbabwe 14.6 16.0 (6.8-20.4) 14.5 (6.6-17.0) 3960 
Weighted 
Average 
21.8 
 
19.9 
 
(8.9-24.9) 
 
17.7 (8.6-21.9) 759846 
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Table 3: Estimated number and proportion of TB disease attributable to tobacco 
smoking by sex among adults in 32 high burden TB countries 
 
 Men   Women   
Country TB 
casesa 
PAF% 
95%CIb 
Excess 
TB 
cases 
TB 
casesa 
PAF%b 
95%CI 
Exces
s TB 
cases 
Afghanistan 6966 22.9 (10.3-28.6) 1598 11890 3.5 (1.4-4.7) 418 
Angola 12488 17.8 (7.7-22.6) 2228 8649 2.0 (0.8-2.7) 176 
Bangladesh 110196 36.8 (18.3-43.9) 40500 70547 1.9 (0.7-2.6) 1349 
Brazil 48489 21.9 (9.7-27.4) 10631 23113 14.6 (6.1-18.6) 3363 
Cambodia 16346 34.5 (16.9-41.5) 5647 14663 4.5 (1.8-5.9) 656 
CAR 2637 17.1 (7.4-21.8) 452 2042 1.9 (0.7-2.6) 39 
China 566364 40.7 (20.9-48.1) 230781 248755 3.0 (1.2-4.0) 7526 
Congo 2308 25.5 (11.6-31.5) 588 1465 2.2 (0.8-2.9) 32 
DRC 41153 15.6 (6.6-19.9) 6413 30748 1.5 (0.6-2.1) 472 
Ethiopia 56799 9.5 (3.9-12.4) 5411 46876 0.6 (0.2-0.9) 303 
India 1010620 24.0 (10.8-29.8) 242613 503218 3.6 (1.4-4.8) 18282 
Indonesia 177044 46.6 (25.1-54.0) 82419 122592 3.4 (1.3-4.5) 4157 
Kenya 49810 19.9 (8.7-25.1) 9908 31036 5.5 (2.2-7.3) 1715 
Lesotho 4803 37.5 (18.8-44.7) 1802 3543 0.6 (0.2-0.9) 23 
Liberia 1126 23.3 (10.5-29.1) 263 531 3.5 (1.4-4.7) 19 
Mozambique 16834 30.0 (14.2-36.6) 5054 11784 7.3 (3.0-9.6) 866 
Myanmar 65260 32.9 (15.9-39.8) 21502 36727 9.6 (3.9-12.5) 3538 
Namibia 4724 30.2 (14.3-36.8) 1427 3241 12.5 (5.2-16.1) 405 
Nigeria 52028 8.7 (3.5-11.3) 4510 33863 0.5 (0.2-0.7) 175 
North Korea 55627 36.3 (18.0-43.4) 20212 33374 0.0 0.0 0 
Pakistan 141052 29.2 (13.7-35.8) 41256 140120 7.0 (2.8-9.2) 9824 
PNG 8799 32.7 (15.7-39.5) 2873 6159 15.7 (6.7-20.6) 966 
Philippines 32479 38.3 (19.3-45.5) 12431 14486 10.5 (4.3-13.6) 1517 
Russia 69153 43.9 (23.1-51.3) 30360 29280 22.0 (9.8-27.5) 6442 
Sera Leone 4635 39.3 (20.0-46.6) 1824 2683 15.8 (6.7-20.1) 423 
South Africa 157748 29.4 (13.8-35.9) 46344 116441 9.2 (3.8-12.0) 10720 
Tanzania 33213 27.3 (12.6-33.6) 9070 21895 4.7 (1.9-6.2) 1031 
Thailand 24613 37.7 (18.9-44.9) 9285 9662 3.3 (1.3-4.4) 316 
Uganda 26702 18.6 (8.1-23.5) 4972 14169 3.4 (1.3-4.5) 480 
Vietnam 37267 38.1 (19.2-45.3) 14209 12518 1.8 (0.7-2.4) 224 
Zambia 20472 24.7 (11.2-30.6) 5052 13024 4.9 (2.0-6.5) 644 
Zimbabwe 15723 26.7 (12.3-32.9) 4196 11640 2.5 (1.0-3.4) 295 
Weighted 
Averagec 
2872945 30.5 (14.9-36.9) 876578 1630361 4.7 (1.9-6.2) 76935 
 
 
a. Number of TB cases reported in 2014 among men and women in each country (WHO, 2015a) 
b. Confidence interval calculated based on RR 2.3 (95%CI, 1.5-2.75) (van Zyl Smit et al., 2010) 
c. The weighted average calculated based on the number of TB cases 
PAF (Population Attributable Fraction), CI (confidence interval), CAR (Central African Republic), DRC 
(Democratic Republic of Congo), PNG (Papua New Guinea) 
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Table 4: Estimated proportion and number of TB deaths attributable to tobacco 
smoking among adults in 32 high burden TB countries 
 
 
 
 
a. TB death attributable to smoking calculated based on relative risk 2.0 (1.1-3.7) (Lin et al., 2007; Slama et al., 
2007 
b. Number of reported deaths: multiplying the cohort number of TB cases by the percent of death in each country 
from WHO report(WHO, 2015d) 
PAF (Population Attributable Fraction), CAR (Central African Republic), DRC (Democratic Republic of Congo), 
CI (Confidence interval), PNG (Papua New Guinea) 
  
 
 
Country Crude PAF % TB Mortality 
(95% CI a) 
Number of 
Deaths 
attributable 
to smoking  
Number 
of TB 
deaths b 
Afghanistan 11.5 (1.3-26) 22 189 
Angola 8.4  (0.9-19.9) 18 211 
Bangladesh 18.7  (2.25-38.3) 1352 7230 
Brazil 14.7  (1.7-31.7) 841 5728 
Cambodia 17.5  (2.1-36.4) 101 620 
CAR 7.9  (0.9-18.8) 18 234 
China 21.9  (2.73-43.1) 1788 8151 
Congo 12.2  (1.4-27.3) 12 75 
DRC 6.0  (0.6-14.7) 173 2876 
Ethiopia 4.12  (0.43-10.4) 142 3110 
India 12.3  (1.4-27.4) 7436 60554 
Indonesia 25.8  (3.4-48.4) 1547 5993 
Kenya 10.4  (1.2-23.9) 504 4,851 
Lesotho 18.4  (2.21-38.0) 237 1168 
Liberia 10.8  (1.2-24.6) 8 232 
Mozambique 15.9  (1.9-33.8) 549 1717 
Myanmar 16.7  (2.0-35.1) 680 4079 
Namibia 17.8  (2.1-36.8) 92 478 
Nigeria 3.8  (0.4-9.5) 193 5153 
North Korea 16.7  (2.0-35.2) 447 2670 
Pakistan 16.0  (1.9-34.0) 451 2812 
PNG  20.8  (2.6-41.5) 125 598 
Philippines 22.1  (2.8-43.3) 207 939 
Russia 28.1  (3.8-51.3) 2490 8859 
Sera Leone 24.2  (3.1-46.3) 56 220 
South Africa 16.3  (1.9-34.4) 3051 19193 
Tanzania 14.0  (1.6-30.6) 463 3306 
Thailand 19.4  (2.3-39.3) 464 2399 
Uganda 9.2  (1.0-21.4) 305 3270 
Vietnam 19.2  (2.3-39.1) 287 1494 
Zambia 12.7  (1.4-28.3) 230 1675 
Zimbabwe 12.7  (1.4-28.3) 388 2736 
Weighted 
Average 
15.0  (1.9-31.6) 24773 162785 
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Table 5. Sensitivity analysis for proportion of TB disease and deaths attributable to 
tobacco smoking based on smoking prevalence 
 
Country Smoking Prevalence  
(95% CI) a 
PAF% TB disease  
(95% CI) b 
PAF % Tb Mortality (95% 
CI) b 
Afghanistan 13.0 (16.1-14.4) 14.4  (11.3-17.3) 11.5 (8.9-13.9) 
Angola 9.2 (5.8-14.1) 10.7  (7.0-15.5) 8.4  (5.5-12.4) 
Bangladesh 23.0 (19.4-28.6)  23.0 (20.1-27.1) 18.7  (16.2-22.2) 
Brazil 17.2 (14.2-21.4) 18.3  (15.6-21.8) 14.7  (12.4-17.6) 
Cambodia 21.2 (16.2-27.3) 21.6  (17.4-26.2) 17.5 (13.9-21.4) 
CAR 8.6 (5.1-12.3)    10.0  (6.2-13.8) 7.9 (4.9-11.0) 
China 28.1 (22.2-32.8) 26.8  (22.4-29.9) 21.9  (18.2-24.7) 
Congo 13.9 (9.9-18.3) 15.3  (11.4-19.2) 12.2  (9.0-15.5) 
DRC 6.4 (4.3-9.2) 7.7  (5.3-10.7) 6.0  (4.1-8.4) 
Ethiopia 4.3 (3.0-5.6)       5.3  (3.8-6.8) 4.1  (2.9-5.3) 
India 14.0 (10.7-16.9) 15.4  (12.2-18.0) 12.3  (9.7-14.5) 
Indonesia 34.8 (28.4-42.9) 31.2  (27.0-35.8) 25.8  (22.1-30.0) 
Kenya 11.6 (6.9-17.9)     13.1  (8.2-18.9) 10.4  (6.5-15.2) 
Lesotho 22.6 (16.6-29.4) 22.7  (17.7-22.7) 18.4  (14.2-22.7) 
Liberia 12.1 (6.5-20.8)     13.6  (7.8-21.3) 10.8  (6.1-17.2) 
Mozambique 18.9 (12.2-27.7) 19.7  (13.7-26.5) 15.9  (10.9-21.7) 
Myanmar 20.0 (16.1-29.6) 20.6  (17.3-27.8) 16.7  (13.9-22.8) 
Namibia 21.6 (15.5-28.8) 21.9  (16.8-27.0) 17.8  (13.4-22.2) 
Nigeria 3.9 (3.9-3.3) 4.8  (4.1-5.5) 3.8  (3.2-4.3) 
North Korea 20.1 (15.1-27.3) 20.7  (16.4-26.2) 16.7  (13.1-21.4) 
Pakistan 19.1 (15.7-27.0) 19.9  (17.0-26.0) 16.0  (13.6-21.3) 
PNG  26.3  (17.5-37.5) 25.5  (18.5-32.8) 20.8  (14.9-27.3) 
Philippines 28.3 (23.2-33.2) 26.9  (23.2-30.1) 22.1  (18.8-24.9) 
Russia 39.1 (31.6-46.4) 33.7  (29.1-37.6) 28.1  (24.0-31.7) 
Sera Leone 31.9 (22.0-42.3) 29.3  (22.2-35.5) 24.2  (18.0-29.7) 
South Africa 19.4 (15.5-24.1) 20.1  (16.8-23.9) 16.3 (13.3-19.4) 
Tanzania 16.3 (11.7-21.3) 17.5  (13.2-21.7) 14.0  (10.5-17.6) 
Thailand 24.0 (20.2-28.1) 23.8  (20.8-26.8) 19.4  (16.8-21.9) 
Uganda 10.1 (7.3-13.6)    11.6  (8.7-15.0) 9.2  (6.8-12.0) 
Vietnam 23.8 (19.8-29.2) 23.6  (20.5-27.5) 19.2  (16.5-22.6) 
Zambia 14.6 (10.0-19.5) 16.0  (11.5-20.2) 12.7  (9.1-16.3) 
Zimbabwe 14.6 (10.8-18.5) 16.0  (12.3-19.4) 12.7  (9.7-15.6) 
Weighted 
Average 
21.8 (17.2-26.3) 19.9  (16.3-23.4) 15.0 (12.1-18.0) 
 
a. Point estimate and 95% CI for smoking prevalence from WHO report (WHO, 2015b) 
b. 95%CI for PAF calculated based on 95% CI for smoking prevalence  
PAF (Population Attributable Fraction), CAR (Central African Republic), DRC (Democratic Republic of Congo), 
CI (Confidence interval), PNG (Papua New Guinea) 
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Figure 1: Smoking prevalence data sources in order of priority  
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Figure 2: Population Attributable Fraction (PAF): definition and formula 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
36 
 
 
 
THESIS REFERENCES  
Alam, D. S., Jha, P., Ramasundarahettige, C., Streatfield, P. K., Niessen, L. W., 
Chowdhury, M. A., . . . Evans, T. G. (2013). Smoking-attributable mortality 
in Bangladesh: proportional mortality study. Bull World Health Organ, 
91(10), 757-764. doi: 10.2471/blt.13.120196 
Alcaide, J., Altet, M. N., Plans, P., Parron, I., Folguera, L., Salto, E., . . . Salleras, 
L. (1996). Cigarette smoking as a risk factor for tuberculosis in young 
adults: a case-control study. Tuber Lung Dis, 77(2), 112-116.  
Anderson, C. L., Becher, H., & Winkler, V. (2016). Tobacco Control Progress in 
Low and Middle Income Countries in Comparison to High Income 
Countries. Int J Environ Res Public Health, 13(10). doi: 
10.3390/ijerph13101039 
Ariyothai, N., Podhipak, A., Akarasewi, P., Tornee, S., Smithtikarn, S., & 
Thongprathum, P. (2004). Cigarette smoking and its relation to pulmonary 
tuberculosis in adults. Southeast Asian J Trop Med Public Health, 35(1), 
219-227.  
Aryanpur, M., Masjedi, M. R., Hosseini, M., Mortaz, E., Tabarsi, P., Soori, H., . . . 
Baikpour, M. (2016). Cigarette smoking in patients newly diagnosed with 
pulmonary tuberculosis in Iran. Int J Tuberc Lung Dis, 20(5), 679-684. doi: 
10.5588/ijtld.15.0662 
Atlas, T. T. Harm. http://www.tobaccoatlas.org/. .    
Atlas, T. T. The Tobacco Atlas Countries. http://www.tobaccoatlas.org/. .    
37 
 
 
 
Bates, M. N., Khalakdina, A., Pai, M., Chang, L., Lessa, F., & Smith, K. R. 
(2007). Risk of tuberculosis from exposure to tobacco smoke: a 
systematic review and meta-analysis. Arch Intern Med, 167(4), 335-342. 
doi: 10.1001/archinte.167.4.335 
Bilano, V., Gilmour, S., Moffiet, T., d'Espaignet, E. T., Stevens, G. A., Commar, 
A., . . . Shibuya, K. (2015). Global trends and projections for tobacco use, 
1990-2025: an analysis of smoking indicators from the WHO 
Comprehensive Information Systems for Tobacco Control. Lancet, 
385(9972), 966-976. doi: 10.1016/s0140-6736(15)60264-1 
Brunet, L., Pai, M., Davids, V., Ling, D., Paradis, G., Lenders, L., . . . Dheda, K. 
(2011). High prevalence of smoking among patients with suspected 
tuberculosis in South Africa. Eur Respir J, 38(1), 139-146. doi: 
10.1183/09031936.00137710 
Bump, J. B., & Reich, M. R. (2013). Political economy analysis for tobacco 
control in low- and middle-income countries. Health Policy Plan, 28(2), 
123-133. doi: 10.1093/heapol/czs049 
Census, U. S. (2015). International Programs. Countries population distribution 
by age and sex. 
http://www.census.gov/population/international/data/idb/informationGatew
ay.php.    
Dhamgaye, T. M. (2008). Tobacco smoking and pulmonary tuberculosis: a case-
control study. Journal of the Indian Medical Association, 106(4), 216-219.  
38 
 
 
 
Gajalakshmi, V., Peto, R., Kanaka, T. S., & Jha, P. (2003). Smoking and 
mortality from tuberculosis and other diseases in India: retrospective study 
of 43000 adult male deaths and 35000 controls. Lancet, 362(9383), 507-
515. doi: 10.1016/s0140-6736(03)14109-8 
Jamal, A., Homa, D. M., O'Connor, E., Babb, S. D., Caraballo, R. S., Singh, T., . . 
. King, B. A. (2015). Current cigarette smoking among adults - United 
States, 2005-2014. MMWR Morb Mortal Wkly Rep, 64(44), 1233-1240. 
doi: 10.15585/mmwr.mm6444a2 
Jee, S. H., Golub, J. E., Jo, J., Park, I. S., Ohrr, H., & Samet, J. M. (2009). 
Smoking and risk of tuberculosis incidence, mortality, and recurrence in 
South Korean men and women. Am J Epidemiol, 170(12), 1478-1485. doi: 
10.1093/aje/kwp308 
Jha, P., Jacob, B., Gajalakshmi, V., Gupta, P. C., Dhingra, N., Kumar, R., . . . 
Peto, R. (2008). A nationally representative case-control study of smoking 
and death in India. N Engl J Med, 358(11), 1137-1147. doi: 
10.1056/NEJMsa0707719 
Jiang, J., Liu, B., Nasca, P. C., Zeng, X., Chen, J., Zou, X., . . . Li, J. (2009). 
Smoking and risk of death due to pulmonary tuberculosis: a case-control 
comparison in 103 population centers in China. Int J Tuberc Lung Dis, 
13(12), 1530-1535.  
Jimenez-Fuentes, M. A., Rodrigo, T., Altet, M. N., Jimenez-Ruiz, C. A., Casals, 
M., Penas, A., . . . Cayla, J. A. (2016). Factors associated with smoking 
39 
 
 
 
among tuberculosis patients in Spain. BMC Infect Dis, 16, 486. doi: 
10.1186/s12879-016-1819-1 
Kolappan, C., & Gopi, P. G. (2002). Tobacco smoking and pulmonary 
tuberculosis. Thorax, 57(11), 964-966.  
Kolappan, C., Gopi, P. G., Subramani, R., & Narayanan, P. R. (2007). Selected 
biological and behavioural risk factors associated with pulmonary 
tuberculosis. Int J Tuberc Lung Dis, 11(9), 999-1003.  
Lam, T. H., Ho, S. Y., Hedley, A. J., Mak, K. H., & Peto, R. (2001). Mortality and 
smoking in Hong Kong: case-control study of all adult deaths in 1998. Bmj, 
323(7309), 361.  
Leung, C. C., Li, T., Lam, T. H., Yew, W. W., Law, W. S., Tam, C. M., . . . Chang, 
K. C. (2004). Smoking and tuberculosis among the elderly in Hong Kong. 
Am J Respir Crit Care Med, 170(9), 1027-1033. doi: 
10.1164/rccm.200404-512OC 
Leung, C. C., Yew, W. W., Chan, C. K., Tam, C. M., Lam, C. W., Chang, K. C., . . 
. Law, W. S. (2003). Smoking and tuberculosis in Hong Kong. Int J Tuberc 
Lung Dis, 7(10), 980-986.  
Lienhardt, C., Fielding, K., Sillah, J. S., Bah, B., Gustafson, P., Warndorff, D., . . . 
McAdam, K. (2005). Investigation of the risk factors for tuberculosis: a 
case-control study in three countries in West Africa. Int J Epidemiol, 34(4), 
914-923. doi: 10.1093/ije/dyi100 
40 
 
 
 
Lin, H. H., Ezzati, M., Chang, H. Y., & Murray, M. (2009). Association between 
tobacco smoking and active tuberculosis in Taiwan: prospective cohort 
study. Am J Respir Crit Care Med, 180(5), 475-480. doi: 
10.1164/rccm.200904-0549OC 
Lin, H. H., Ezzati, M., & Murray, M. (2007). Tobacco smoke, indoor air pollution 
and tuberculosis: a systematic review and meta-analysis. PLoS Med, 4(1), 
e20. doi: 10.1371/journal.pmed.0040020 
Lonnroth, K., Castro, K. G., Chakaya, J. M., Chauhan, L. S., Floyd, K., Glaziou, 
P., & Raviglione, M. C. (2010). Tuberculosis control and elimination 2010-
50: cure, care, and social development. Lancet, 375(9728), 1814-1829. 
doi: 10.1016/s0140-6736(10)60483-7 
Lonnroth, K., Roglic, G., & Harries, A. D. (2014). Improving tuberculosis 
prevention and care through addressing the global diabetes epidemic: 
from evidence to policy and practice. Lancet Diabetes Endocrinol, 2(9), 
730-739. doi: 10.1016/s2213-8587(14)70109-3 
Mahishale, V., Patil, B., Lolly, M., Eti, A., & Khan, S. (2015). Prevalence of 
Smoking and Its Impact on Treatment Outcomes in Newly Diagnosed 
Pulmonary Tuberculosis Patients: A Hospital-Based Prospective Study. 
Chonnam Med J, 51(2), 86-90. doi: 10.4068/cmj.2015.51.2.86 
Maurya, V., Vijayan, V. K., & Shah, A. (2002). Smoking and tuberculosis: an 
association overlooked. Int J Tuberc Lung Dis, 6(11), 942-951.  
41 
 
 
 
Mendez, D., Alshanqeety, O., & Warner, K. E. (2013). The potential impact of 
smoking control policies on future global smoking trends. Tob Control, 
22(1), 46-51. doi: 10.1136/tobaccocontrol-2011-050147 
Noeske, J., Nana Yakam, A., & Abena Foe, J. L. (2016). Epidemiology of 
tuberculosis in Cameroon as mirrored in notification data, 2006-2014. Int J 
Tuberc Lung Dis, 20(11), 1489-1494. doi: 10.5588/ijtld.16.0252 
Ozturk, A. B., Kilicaslan, Z., & Issever, H. (2014). Effect of smoking and indoor air 
pollution on the risk of tuberculosis: smoking, indoor air pollution and 
tuberculosis. Tuberk Toraks, 62(1), 1-6.  
Pednekar, M. S., & Gupta, P. C. (2007). Prospective study of smoking and 
tuberculosis in India. Prev Med, 44(6), 496-498. doi: 
10.1016/j.ypmed.2007.02.017 
Prasad, R., Garg, R., Singhal, S., Dawar, R., & Agarwal, G. G. (2009). A case-
control study of tobacco smoking and tuberculosis in India. Ann Thorac 
Med, 4(4), 208-210. doi: 10.4103/1817-1737.56007 
Prignot, J. J., Sasco, A. J., Poulet, E., Gupta, P. C., & Aditama, T. Y. (2008). 
Alternative forms of tobacco use. Int J Tuberc Lung Dis, 12(7), 718-727.  
Ramin, B., Kam, D., Feleke, B., Jacob, B., & Jha, P. (2008). Smoking, HIV and 
non-fatal tuberculosis in an urban African population. Int J Tuberc Lung 
Dis, 12(6), 695-697.  
Rao, V. G., Bhat, J., Yadav, R., Muniyandi, M., Bhondeley, M. K., Sharada, M. 
A., . . . Wares, D. F. (2014). Tobacco smoking: a major risk factor for 
42 
 
 
 
pulmonary tuberculosis--evidence from a cross-sectional study in central 
India. Trans R Soc Trop Med Hyg, 108(8), 474-481. doi: 
10.1093/trstmh/tru082 
Sitas, F., Urban, M., Bradshaw, D., Kielkowski, D., Bah, S., & Peto, R. (2004). 
Tobacco attributable deaths in South Africa. Tob Control, 13(4), 396-399. 
doi: 10.1136/tc.2004.007682 
Slama, K., Chiang, C. Y., Enarson, D. A., Hassmiller, K., Fanning, A., Gupta, P., 
& Ray, C. (2007). Tobacco and tuberculosis: a qualitative systematic 
review and meta-analysis. Int J Tuberc Lung Dis, 11(10), 1049-1061.  
Smith, G. S., Van Den Eeden, S. K., Baxter, R., Shan, J., Van Rie, A., Herring, A. 
H., . . . Gammon, M. D. (2015). Cigarette smoking and pulmonary 
tuberculosis in northern California. J Epidemiol Community Health, 69(6), 
568-573. doi: 10.1136/jech-2014-204292 
Stevenson, C. R., Forouhi, N. G., Roglic, G., Williams, B. G., Lauer, J. A., Dye, 
C., & Unwin, N. (2007). Diabetes and tuberculosis: the impact of the 
diabetes epidemic on tuberculosis incidence. BMC Public Health, 7, 234. 
doi: 10.1186/1471-2458-7-234 
van Zyl Smit, R. N., Pai, M., Yew, W. W., Leung, C. C., Zumla, A., Bateman, E. 
D., & Dheda, K. (2010). Global lung health: the colliding epidemics of 
tuberculosis, tobacco smoking, HIV and COPD. Eur Respir J, 35(1), 27-
33. doi: 10.1183/09031936.00072909 
43 
 
 
 
Viney, K., Hoy, D., Roth, A., Kelly, P., Harley, D., & Sleigh, A. (2015). The 
epidemiology of tuberculosis in the Pacific, 2000 to 2013. Western Pac 
Surveill Response J, 6(3), 59-67. doi: 10.5365/wpsar.2015.6.3-059 
Wang, J. Y., Hsueh, P. R., Jan, I. S., Lee, L. N., Liaw, Y. S., Yang, P. C., & Luh, 
K. T. (2007). The effect of smoking on tuberculosis: different patterns and 
poorer outcomes. Int J Tuberc Lung Dis, 11(2), 143-149.  
WHO. Tobacco Free Initiative (TFI) . Tobacco control country profiles. 
http://www.who.int/tobacco/surveillance/policy/country_profile/en/.    
WHO. Tobacco Free Initiative. http://www.who.int/tobacco/about/en/.  
WHO. (2008). A POLICY PACKAGE TO REVERSE THE TOBACCO EPIDEMIC. 
MPOWER.  http://www.who.int/tobacco/mpower/mpower_english.pdf.    
WHO. (2011). WHO Global TB Control. 
http://apps.who.int/iris/bitstream/10665/44728/1/9789241564380_eng.pdf.  
WHO. (2013a). Global TB Report. 
http://apps.who.int/iris/bitstream/10665/91355/1/9789241564656_eng.pdf.  
WHO. (2013b). TB Notification rate. 
http://www.who.int/healthinfo/indicators/2015/chi_2015_45_tb_notification.
pdf.  
WHO. (2014). Unite To End TB. HIGHLIGHTS FROM  THE 30 HIGHEST TB  
BURDEN COUNTRIES. 
http://apps.who.int/iris/bitstream/10665/204662/1/WHO_HTM_TB_2016.0
6_eng.pdf?ua=1.    
44 
 
 
 
WHO. (2015a). Global tuberculosis report 2015. 
http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf
?ua=1.    
WHO. (2015b). WHO global report on trends in prevalence of tobacco smoking.  
http://apps.who.int/iris/bitstream/10665/156262/1/9789241564922_eng.pdf
?ua=1.    
WHO. (2015c). WHO Report on the Global Tobacco Epidemic. 
MPOWER.http://apps.who.int/iris/bitstream/10665/178574/1/97892406946
06_eng.pdf?ua=1&ua=1.  
WHO. (2015d). World Health Organization. Global tuberculosis report 2015. 
http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf
?ua=1.    
WHO. (2015e). World Health Organization. UN Sustainable Development 
Summit 2015. http://www.who.int/mediacentre/events/meetings/2015/un-
sustainable-development-summit/en/.  
WHO. (2016a). Global Tuberculosis Report. 
http://www.who.int/tb/publications/global_report/en/.    
WHO. (2016b, June, 2016). Tobacco. key Fact sheet. 
http://www.who.int/mediacentre/factsheets/fs339/en/.   Retrieved 
September.9, 2016 
WHO. (2016c). Tuberculosis. Key Facts. 
http://www.who.int/mediacentre/factsheets/fs104/en/.    
45 
 
 
 
WHO. (October 2015 ). Global Adult Tobacco Survey (GATS). from 
http://www.who.int/tobacco/surveillance/survey/gats/en/ 
Yen, Y., Yen, M., Lin, Y., Lin, Y., Shih, H., Li, L., . . . Deng, C. (2014). Smoking 
increases risk of recurrence after successful anti-tuberculosis treatment: a 
population-based study. The International Journal of Tuberculosis and 
Lung Disease, 18(4), 492-498.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
46 
 
 
 
APPENDICES 
Notified adult tuberculosis (TB) cases, TB deaths, and smoking prevalence in 32 
high TB burden countries 
 
Country, Year a Population 
(2014) b 
Smoking 
Prevalence c 
Number of 
notified TB 
cases d 
Number of TB 
deaths 
Afghanistan, 
2013 
    
Male 9,346,537 22.9 6,966  
Female 9,103,091 2.8 11,890  
Overall 18,449,628 13.0 18,856 189 
Angola, 2013     
Male  5,444,937 16.7 12,488  
Female 5,392,622 1.6 8,649  
Overall 10,837,559 9.2 21,137 211 
Bangladesh, 
2009 
    
Male 53,537,731 44.7 70,547  
Female 59,005,538 1.5 110,196  
Overall 112,543,269 23 180,743 7,230 
Brazil, 2010     
Male 73,337,384 21.6 484,89  
Female 74,633,794 13.1 231,13  
Overall 148,971,178 17.2 71,602 5,728 
Cambodia, 2014     
Male 5,031,918 39.1 16,346  
Female 5,542,136 3.4 14,663  
Overall 10,574,054 19.5 31,009 620 
CAR, 2013     
Male 1,538,351 15.9 2,637  
Female 1,597,701 1.5 2,042  
Overall 3,136,052 8.6 4,679 234 
China, 2010     
Male 574,572,913 52.9 566,364  
Female 553,862,448 2.4 248,755  
Overall 1,128,435,361 28.1 815,119 8,151 
Congo, 2013     
Male 1,370,639 35.5 2,308  
Female 1,374,544 1.7 1,465  
Overall 2,745,183 18.5 3,773 75 
DRC, 2009     
Male 21,789,564 14.2 41,153  
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Female 22,280,946 1.2 30,748  
Overall 44,070,510 6.4 71,901 2,876 
Ethiopia, 2013     
Male 26,649,453 8.9 56,799  
Female 27,299,308 0.5 46,876  
Overall 53,948,761 4.7 103,675 3,170 
India, 2010     
Male 454,657,918 24.3 1,010,620  
Female 429,621,617 2.9 503,218  
Overall 884,279,535 14 1,513,838 60,554 
Indonesia, 2011     
Male 93,002,868 67 177044  
Female 94,103,687 2.7 122592  
Overall 187,106,555 34.8 299636 5,993 
Kenya, 2014     
Male 12,955,774 19.1 49,810  
Female 13,123,504 4.5 31,036  
Overall 26,079,278 11.6 80,846 4,851 
Lesotho, 2013     
Male 637,600 51.7 4,803  
Female 665,126 0.4 3,543  
Overall 1,302,726 25.4 8,346 1,168 
Liberia, 2013     
Male 1,149,168 25.9 1,126  
Female 1,175,485 2.6 531  
Overall 2,324,653 14.2 1,657 66 
Mozambique, 
2013 
    
Male 6,416,394 32.7 16,834  
Female 7,082,374 6.1 11,783  
Overall 13,498,768 18.8 28,617 1,717 
Myanmar, 2013     
Male 20,208,558 37.8 65,260  
Female 20,829,928 8.2 36,727  
Overall 41,038,486 20 101,987 4,079 
Namibia, 2013     
Male 757,230 37 4,724  
Female 743,215 11.7 3,241  
overall 1,500,445 23.8 7,965 478 
Nigeria, 2012     
Male 51,199,237 7.3 52,028  
Female 49,451,476 0.4 33,863  
Overall 100,650,713 3.9 85,891 5,153 
North Korea, 
2014 
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Male 8,957,144 43.9 55,627  
Female 9,790,762 0 33,374  
Overall 18,747,906 20.1 89,001 2,670 
Pakistan, 2014     
Male 67,153,607 31.8 141,052  
Female 63,627,058 5.8 140,120  
Overall 130,780,665 19.1 281,172 2,812 
PNG, 2014      
Male 2,186,176 37.3 8,799  
Female        2,075,539 14.5 6,159  
Overall 4,261,715 26.3 14,958 598 
Philippines, 2010     
Male 32,498,235 47.7 32,479  
Female 32,774,610 9 14,486  
Overall 65,272,845 28.3 46,965 939 
Russia, 2009     
Male 53,950,453 60.2 69,153  
Female 65,194,863 21.7 29,280  
Overall 119,145,316 39.1 98,433 8,859 
Sera Leone, 2013      
Male 1,590,157 56.4 4,635  
Female 1,746,240 12.9 2,683  
Overall 3,336,397 34.4 7,318 220 
South Africa, 
2013 
    
Male 18,630,731 31.9 157,748  
Female 1,924,5128 7 116,441  
Overall 3,7875,859 18.9 274,189 19,193 
Tanzania, 2014     
Male 13,553,042 28.8 33,213  
Female 13,950,255 3.9 21,895  
Overall 27,503,297 16.3 55,108 3,306 
Thailand, 2011     
Male 27,179,252 46.6 24,613  
Female 28,616,175 2.6 9,662  
Overall 55,795,427 24 34,275 2,399 
Uganda, 2013     
Male 9,127,278 17.5 26,702  
Female 9,311,383 3.1 14,169  
Overall 18,438,661 10.3 40,871 3,270 
Vietnam, 2010     
Male 34,766,213 47.4 37,267  
Female 35,908,364 1.4 12,518  
Overall 70,674,577 23.8 49,785 1,494 
Zambia, 2013     
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Male 3,921,346 27.1 20472  
Female 3,960,921 4.7 13024  
Overall 7,882,267 15.9 33496 1675 
Zimbabwe, 2015  16.50   
Male 4,200,258 31.2 15,723  
Female 4,285,381 2.1 11,640  
Overall 8,485,639 16.5 27,363 2,736 
Total 3,359,683,285 21.7 4,504,212 162,821 
  
a. Smoking prevalence data year 
b. Population age 15 years and up (Census, 2015) 
c. Prevalence of current tobacco smoking (Atlas; WHO, October 2015 ) 
d. New and relapse pulmonary TB (bacteriologically confirmed and clinically diagnosed) and Extra-pulmonary TB 
cases reported to WHO.(WHO, 2015d) 
PAF (Population Attributable Fraction), CAR (Central African Republic), DRC (democratic Republic of Congo), 
PNG (Papua New Guinea) 
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Estimated proportion of active TB attributable to smoking with age distribution for 
some countries. 
 
Countries with age 
and sex  
Smoking 
Prevalence a 
Active TB PAF (%)  
 (95% CI) b 
Excess 
number of TB 
cases 
Brazil     
Men age in year     
15-24 14.8 16.1 (6.9-20.6) 1,234 
25-44 22.5 22.6 (10.1-28.3) 4,773 
45-64 28.1 26.8 (12.3-33.0) 3,943 
>65 17.3 18.4 (8.0-23.2) 537 
Women age in year     
15-24 6.4 7.7 (3.1-10.1) 343 
25-44 14.5 15.9 (6.8-20.2) 1,529 
45-64 17.9 18.9 (8.2-23.9) 1,144 
>65 9.3 10.8 (4.4-14.0) 163 
     
Over all(crude)  18.3 (7.9-23.1) 13,085 
Age Adjusted  18.2 (7.9-22.9) 13,666 
China     
Men age in year     
15-24 33.6 30.4 (14.4-37.0) 24,719 
25-44 59.3 43.5 (22.9-50.9) 64,513 
45-64 63 45.0 (24.0-52.4) 93,386 
>65 40.2 34.3  (16.7-41.3) 43,864 
Women age in year     
15-24 0.7 0.9 (0.4-1.2) 407 
25-44 1.6 2.0 (0.8-2.7) 1,575 
45-64 3.2 4.0 (1.6-5.3) 3,043 
>65 6.7 8.0 (3.2-10.5) 3,983 
     
Over all(crude)  26.8 (12.3-33.0) 218,093 
Age Adjusted  22.2  (11.3-26.4) 235,490 
India     
Men age in year     
15-24 9.7 11.2 (4.6-14.5) 19,007 
25-44 27.0 26.0 (11.9-32.1) 98,604 
45-64 37.4 32.7  (15.8-39.6) 106,147 
>65 31.0 28.7  (13.4-35.2) 29,904 
Women age in year    18,282 
15-24 0.3 0.4  (0.1-0.5) 536 
25-44 2.1 2.7  (1.0-3.5) 5,505 
45-64 5.7 6.9  (2.8-9.1) 7,340 
>65 9.9 11.4  (4.7-14.8) 3,492 
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Over all(crude)  15.4 (6.5-19.7) 233,095 
Age adjusted  14.2 (6.4-17.7) 270,534 
Indonesia     
Men age in year     
15-24 51.7 40.2  (20.5-47.5) 10,822 
25-44 73.3 48.8  (26.8-56.2) 34,305 
45-64 72.4 48.5  (26.6-55.9) 30,246 
>65 61.2 44.3  (23.4-51.7) 9,413 
Women age in year     
15-24 0.1 0.1  (0.0-0.2) 33 
25-44 1.7 2.2  (0.8-2.9) 1,059 
45-64 5.8 7.0  (2.8-9.2) 2,872 
>65 6.7 8.0  (3.2-10.5) 850 
     
Over all(crude)  31.1  (14.8-37.8) 93,332 
Age adjusted  24.8  (13.1-29.1) 89,599 
Kenya     
Men age in year     
15-24 4.9 6.0  (2.4-7.9) 490 
25-44 23 23.0  (10.3-28.7) 6775 
45-64 36.2 32.0  (15.3-38.8) 3370 
>65 30.9 28.7  (13.4-35.1) 759 
Women age in year     
15-24 0.7 0.9  (0.3-1.2) 60 
25-44 2.7 3.4  (1.3-4.5) 594 
45-64 10.9 12.4  (5.2-16.0) 685 
>65 21.7 22.0  (9.8-27.5) 388 
     
Over all(crude)  13.1 (5.5-16.9) 10,594 
Adjusted  12.1 (5.4-15.2) 13,121 
Russia     
Men age in year     
15-24 46.1 37.5 (18.7-44.7) 1,731 
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25-44 68.3 47.0 (25.5-54.4) 18,326 
45-64 62.4 44.8 (23.8-52.2) 10,044 
>65 40.3 34.4 (16.8-41.4) 1,074 
Women age in year     
15-24 55.7 42.0 (21.8-49.4) 1,414 
25-44 31.3 28.9 (13.5-35.4) 4,636 
45-64 18.2 19.1 (8.3-24.2) 1,311 
>65 2.9 3.6 (1.4-4.8) 105 
     
Over all(crude)  33.7 (16.4-40.6) 33,172 
Adjusted  31.8 (16.0-37.8) 38,640 
